Tech Company Financing Transactions
Nabla Bio Funding Round
Nabla Bio closed a $11 million Seed funding round on 12/7/2021. Backers included Khosla Ventures, Zetta Venture Partners and Cantos Ventures.
Transaction Overview
Company Name
Announced On
12/7/2021
Transaction Type
Venture Equity
Amount
$11,000,000
Round
Seed
Investors
Khosla Ventures (Lead Investor) (Alex Morgan)
Zetta Venture Partners (Lead Investor) (Dylan Reid)
Proceeds Purpose
The new funding will be used to accelerate development of an AI-first protein design platform, enabling rapid end-to-end engineering of next-generation antibody therapeutics.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
127 Western Ave.
Boston, MA 02134
USA
Boston, MA 02134
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Nabla Bio is an antibody design company. The company's AI-first protein design platform enables rapid engineering of best-in-class antibody therapeutics.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Surge Biswas
Browse more venture capital transactions:
Prev: 12/7/2021: Kasada venture capital transaction
Next: 12/7/2021: TradeDepot venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on tech company VC transactions. VC investment data records reported here come from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs